Investor's Business Daily on MSN15d
BridgeBio, ARS Pharma, Harmony Bio Shine At JPM. But SpringWorks, Beam Take Their Lumps.Biotech stocks put up a split showing at JPM, where names like BridgeBio, ARS and Harmony stood out with strong preliminary ...
Holdings Inc. (“Company” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing ...
Koreas biotech firms strive for growth amid investment challenges at JP Morgan event K-Bio executives highlight new ...
Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced its latest business achievements and 2025 outlook at the 43rd J.P. Morgan ...
Hosted on MSN15d
At J.P. Morgan Healthcare Conference, Korean pharmaceuticals set to share strategies, seal dealsThe 43rd J.P. Morgan Healthcare Conference in San Francisco will see active participation by Korean pharmaceutical giants and up-and-comers, from featured presentations to deal making.
Local biotech leaders are heading to San Francisco for the 2025 J.P. Morgan Healthcare Conference, one of the industry's biggest annual events. Hotels have been booked, the meetings scheduled and ...
Korea’s top biopharmaceutical firms, Celltrion and Samsung Biologics, envisioned their future strategies for expansion at J.P ...
OraSure Technologies CEO Carrie Eglinton Manner said in her presentation that the firm's recent $25 million acquisition of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback